Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Dapsone for primary immune thrombocytopenia in adults and children: an evidence-based review.

Rodrigo C, Gooneratne L.

J Thromb Haemost. 2013 Nov;11(11):1946-53. doi: 10.1111/jth.12371. Review.

2.

[Treatment outcome of immune thrombocytopenia].

Iványi JL, Marton E, Plander M.

Orv Hetil. 2012 Oct 14;153(41):1613-21. doi: 10.1556/OH.2012.29456. Hungarian.

PMID:
23045311
3.

Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab.

Zaja F, Marin L, Chiozzotto M, Puglisi S, Volpetti S, Fanin R.

Am J Hematol. 2012 Mar;87(3):321-3. doi: 10.1002/ajh.22266. Epub 2011 Dec 21.

4.

Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.

Vancine-Califani SM, De Paula EV, Ozelo MC, Orsi FL, Fabri DR, Annichino-Bizzacchi JM.

Platelets. 2008 Nov;19(7):489-95. doi: 10.1080/09537100802315110.

PMID:
18979360
5.

Childhood immune thrombocytopenia: role of rituximab, recombinant thrombopoietin, and other new therapeutics.

Journeycake JM.

Hematology Am Soc Hematol Educ Program. 2012;2012:444-9. doi: 10.1182/asheducation-2012.1.444. Review.

PMID:
23233617
6.

Sequence of treatments for adults with primary immune thrombocytopenia.

George JN.

Am J Hematol. 2012 May;87 Suppl 1:S12-5. doi: 10.1002/ajh.23132. Epub 2012 Mar 3. Review.

7.

Exposure to non-corticosteroid treatments in adult primary immune thrombocytopenia before the chronic phase in the era of thrombopoietin receptor agonists in France. A nationwide population-based study.

Moulis G, Lapeyre-Mestre M, Montastruc JL, Sailler L.

Autoimmun Rev. 2015 Feb;14(2):168-73. doi: 10.1016/j.autrev.2014.10.017. Epub 2014 Oct 16.

PMID:
25461471
8.

ITP and international guidelines: what do we know, what do we need?

Rodeghiero F, Ruggeri M.

Presse Med. 2014 Apr;43(4 Pt 2):e61-7. doi: 10.1016/j.lpm.2014.02.004. Epub 2014 Mar 20. Review.

PMID:
24656296
9.

[Treatment of immune thrombocytopenia: a retrospective study of 40 patients].

Audia S, Lakomy D, Guy J, Leguy-Seguin V, Berthier S, Aho S, Lorcerie B, Bonnotte B.

Rev Med Interne. 2010 May;31(5):337-44. doi: 10.1016/j.revmed.2009.11.008. Epub 2010 Apr 20. French.

PMID:
20409619
10.

Dapsone for immune thrombocytopenic purpura in children and adults.

Patel AP, Patil AS.

Platelets. 2015;26(2):164-7. doi: 10.3109/09537104.2014.886677. Epub 2014 Feb 10.

PMID:
24512442
11.

Therapeutic options for immune-mediated thrombocytopenia.

Nakamura RK, Tompkins E, Bianco D.

J Vet Emerg Crit Care (San Antonio). 2012 Feb;22(1):59-72. doi: 10.1111/j.1476-4431.2011.00705.x. Epub 2012 Jan 25.

PMID:
22316417
12.

Age old dapsone in the treatment of idiopathic thrombocytopenic purpura--a case report with review.

Kundu R, Sethi N, Ghose A, Chaudhary R.

Am J Ther. 2013 Nov-Dec;20(6):e723-5. doi: 10.1097/MJT.0b013e3182204fbb. Review.

PMID:
21822117
13.

Should rituximab be used before or after splenectomy in patients with immune thrombocytopenic purpura?

Cooper N, Evangelista ML, Amadori S, Stasi R.

Curr Opin Hematol. 2007 Nov;14(6):642-6. Review.

PMID:
17898569
14.

Pathophysiology and management of primary immune thrombocytopenia.

Kashiwagi H, Tomiyama Y.

Int J Hematol. 2013 Jul;98(1):24-33. doi: 10.1007/s12185-013-1370-4. Epub 2013 May 24. Review.

PMID:
23702914
15.

[Immune thrombocytopenias: pathophysiology and treatment].

Godeau B.

Bull Acad Natl Med. 2013 Feb;197(2):407-17. French.

PMID:
24919370
16.

[New treatment methods for autoimmune thrombocytopenia].

Koene HR.

Ned Tijdschr Geneeskd. 2007 Nov 24;151(47):2609-14. Review. Dutch.

PMID:
18161261
17.

What's new in the management of chronic primary immune thrombocytopenia in adults and the use of thrombopoietin receptor agonists.

Newland A.

Med Princ Pract. 2011;20(4):301-2. doi: 10.1159/000324876. Epub 2011 May 11. No abstract available.

18.

Treatment of immune thrombocytopenic purpura in adults.

Bussel J.

Semin Hematol. 2006 Jul;43(3 Suppl 5):S3-10; discussion S18-9. Review.

PMID:
16815346
19.

Dapsone for chronic autoimmune thrombocytopenic purpura: a report of 66 cases.

Godeau B, Durand JM, Roudot-Thoraval F, Tennezé A, Oksenhendler E, Kaplanski G, Schaeffer A, Bierling P.

Br J Haematol. 1997 May;97(2):336-9.

PMID:
9163598
20.

Current therapies in primary immune thrombocytopenia.

Pels SG.

Semin Thromb Hemost. 2011 Sep;37(6):621-30. doi: 10.1055/s-0031-1291372. Epub 2011 Nov 18. Review.

PMID:
22102265

Supplemental Content

Support Center